<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37434326</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1471-8391</ISSN><JournalIssue CitedMedium="Internet"><Volume>147</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>British medical bulletin</Title><ISOAbbreviation>Br Med Bull</ISOAbbreviation></Journal><ArticleTitle>Long COVID: what is known and what gaps need to be addressed.</ArticleTitle><Pagination><StartPage>6</StartPage><EndPage>19</EndPage><MedlinePgn>6-19</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bmb/ldad016</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Long COVID is a chronic condition that follows after acute COVID-19 and is characterized by a wide range of persistent, cyclic symptoms.</AbstractText><AbstractText Label="SOURCES OF DATA">PubMed search for publications featuring 'Long COVID' or 'post-acute sequelae of COVID-19'.</AbstractText><AbstractText Label="AREAS OF AGREEMENT">Long COVID occurs frequently post-acute COVID-19, with a majority of people experiencing at least one symptom (such as cough, fatigue, myalgia, anosmia and dyspnoea) 4&#xa0;weeks after infection.</AbstractText><AbstractText Label="AREAS OF CONTROVERSY">The specific symptoms and the minimum duration of symptoms required to be defined as Long COVID.</AbstractText><AbstractText Label="GROWING POINTS">There is a consistent reduction in Long COVID incidence amongst vaccinated individuals, although the extent of this effect remains unclear.</AbstractText><AbstractText Label="AREAS TIMELY FOR DEVELOPING RESEARCH">There is an urgent need to understand the causes of Long COVID, especially extreme fatigue more than 6&#xa0;months after infection. We must understand who is at risk and whether reinfections similarly risk Long COVID.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Krishna</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Cambridge Institute of Therapeutic Immunology &amp; Infectious Disease (CITIID), Cambridge CB2 0AW, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wills</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cambridge Institute of Therapeutic Immunology &amp; Infectious Disease (CITIID), Cambridge CB2 0AW, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sithole</LastName><ForeName>Nyaradzai</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cambridge Institute of Therapeutic Immunology &amp; Infectious Disease (CITIID), Cambridge CB2 0AW, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>G112259</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>225023/Z/22/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br Med Bull</MedlineTA><NlmUniqueID>0376542</NlmUniqueID><ISSNLinking>0007-1420</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">causes</Keyword><Keyword MajorTopicYN="N">symptoms</Keyword><Keyword MajorTopicYN="N">treatments</Keyword></KeywordList><CoiStatement>The authors have no potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>18</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>12</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37434326</ArticleId><ArticleId IdType="pmc">PMC10502447</ArticleId><ArticleId IdType="doi">10.1093/bmb/ldad016</ArticleId><ArticleId IdType="pii">7222690</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian &#xa0;A, Sehgal &#xa0;K, Gupta &#xa0;A, et al. &#xa0;Post-acute COVID-19 syndrome. Nat Med &#xa0;2021;27:601&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco &#xa0;AL, Pacheco &#xa0;RL, Bagattini &#xa0;&#xc2;M, et al. &#xa0;Frequency, signs and symptoms, and criteria adopted for Long COVID-19: a systematic review. Int J Clin Pract &#xa0;2021;75:e14357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis &#xa0;HE, Assaf &#xa0;GS, McCorkell &#xa0;L, et al. &#xa0;Characterizing Long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine &#xa0;2021;38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider &#xa0;C, Laurent &#xa0;E, Lemaignen &#xa0;A, et al. &#xa0;Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect &#xa0;2021;27:258&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampl &#xa0;BMJ, Buczovsky &#xa0;M, Martin &#xa0;G, et al. &#xa0;Clinical and epidemiological data of COVID-19 from Regensburg, Germany: a retrospective analysis of 1084 consecutive cases. Infection &#xa0;2021;49:661&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7934115</ArticleId><ArticleId IdType="pubmed">33666894</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekstr&#xf6;m &#xa0;S, Andersson &#xa0;N, L&#xf6;vquist &#xa0;A, et al. &#xa0;COVID-19 among young adults in Sweden: self-reported long-term symptoms and associated factors. Scand J Public Health &#xa0;2022;50:85&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8808012</ArticleId><ArticleId IdType="pubmed">34148461</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; &#xa0;A, Bernabei &#xa0;R, Landi &#xa0;F, et al. &#xa0;Persistent symptoms in patients after acute COVID-19. JAMA &#xa0;2020;324:603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang &#xa0;C, Huang &#xa0;L, Wang &#xa0;Y, et al. &#xa0;6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet &#xa0;2021;397:220&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre &#xa0;CH, Murray &#xa0;B, Varsavsky &#xa0;T, et al. &#xa0;Attributes and predictors of Long COVID. Nat Med &#xa0;2021;27:626&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez &#xa0;O, Merino &#xa0;E, Leon-Ramirez &#xa0;J-M, et al. &#xa0;Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect &#xa0;2021;82:378&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen &#xa0;MS, Kristiansen &#xa0;MF, Hanusson &#xa0;KD, et al. &#xa0;Long COVID in the Faroe Islands-a longitudinal study among non-hospitalized patients. Clin Infect Dis &#xa0;2020;73:e4058&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet &#xa0;M, Dercon &#xa0;Q, Harrison &#xa0;PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun 2022;103:154&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson &#xa0;EJ, Williams &#xa0;DM, Walker &#xa0;AJ, et al. &#xa0;Risk factors for Long COVID: analyses of 10 longitudinal studies and electronic health records in the UK. Nat Commun 2022;13:3528. 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Nice &#xa0;S. COVID-19 rapid guideline: managing the long-term effects of COVID-19. Royal College of general practitioners. NICE &#x2018;Long COVID&#x2019; guideline &#xa0;2021;1:1&#x2013;5.</Citation></Reference><Reference><Citation>Davis &#xa0;HE, McCorkell &#xa0;L, Vogel &#xa0;JM, et al. &#xa0;Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol &#xa0;2023;21:133&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal &#xa0;AD, VanElzakker &#xa0;MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol &#xa0;2021;12:1494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner &#xa0;S, Khan &#xa0;MA, Putrino &#xa0;D, et al. &#xa0;Long COVID: pathophysiological factors and abnormalities of coagulation. Trends Endocrinol Metab &#xa0;2023;34:321&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez &#xa0;O, Merino &#xa0;E, Leon-Ramirez &#xa0;J-M, et al. &#xa0;Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect &#xa0;2021;82:378&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme &#xa0;M, Braillard &#xa0;O, Alcoba &#xa0;G, et al. &#xa0;COVID-19 symptoms: longitudinal evolution and persistence in outpatient settings. Ann Intern Med &#xa0;2021;174:723&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7741180</ArticleId><ArticleId IdType="pubmed">33284676</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Gonz&#xe1;lez &#xa0;A, Ara&#xfa;jo-Ameijeiras &#xa0;A, Fern&#xe1;ndez-Villar &#xa0;A, et al. &#xa0;Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study. Sci Rep &#xa0;2022;12:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8888560</ArticleId><ArticleId IdType="pubmed">35233035</ArticleId></ArticleIdList></Reference><Reference><Citation>van &#xa0;Kessel &#xa0;SA, Olde Hartman &#xa0;TC, Lucassen &#xa0;PL, et al. &#xa0;Post-acute and Long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract &#xa0;2022;39:159&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan &#xa0;M, Soddu &#xa0;D, Balbo &#xa0;PE, et al. &#xa0;Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open &#xa0;2021;4:e2036142&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>El Sayed &#xa0;S, Shokry &#xa0;D, Gomaa &#xa0;SM. Post-COVID-19 fatigue and anhedonia: a cross-sectional study and their correlation to post-recovery period. Neuropsychopharmacol Rep &#xa0;2021;41:50&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8182964</ArticleId><ArticleId IdType="pubmed">33332756</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues &#xa0;E, Janvier &#xa0;P, Kherabi &#xa0;Y, et al. &#xa0;Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect &#xa0;2020;81:e4&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj &#xa0;E, Campion &#xa0;JY, Dudouet &#xa0;P, et al. &#xa0;18F-FDG brain PET hypometabolism in patients with Long COVID. Eur J Nucl Med Mol Imaging &#xa0;2021;48:2823&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs &#xa0;LG, Gourna Paleoudis &#xa0;E, Lesky-Di Bari &#xa0;D, et al. &#xa0;Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PloS One &#xa0;2020;15:e0243882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang &#xa0;L, Yang &#xa0;B, Jiang &#xa0;N, Fu &#xa0;W, He &#xa0;X, Zhou &#xa0;Y, Ma &#xa0;W-L, Wang &#xa0;X. Three-month follow-up study of survivors of coronavirus disease 2019 after discharge. J Korean Med Sci &#xa0;2020;35:e418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7721559</ArticleId><ArticleId IdType="pubmed">33289374</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth &#xa0;NC, Kim &#xa0;A, Vitkovski &#xa0;T, et al. &#xa0;Post&#x2013;COVID-19 cholangiopathy: a novel entity. Am J Gastroenterol &#xa0;2021;116:1077&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">33464757</ArticleId></ArticleIdList></Reference><Reference><Citation>Simani &#xa0;L, Ramezani &#xa0;M, Darazam &#xa0;IA, et al. &#xa0;Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. J Neurovirol &#xa0;2021;27:154&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852482</ArticleId><ArticleId IdType="pubmed">33528827</ArticleId></ArticleIdList></Reference><Reference><Citation>van den &#xa0;Borst &#xa0;B, Peters &#xa0;JB, Brink &#xa0;M, et al. &#xa0;Comprehensive health assessment 3 months after recovery from acute coronavirus disease 2019 (COVID-19). Clin Infect Dis &#xa0;2021;73:e1089&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao &#xa0;Y-m, Shang &#xa0;Y-m, Song &#xa0;W-b, et al. &#xa0;Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine &#xa0;2020;25:100463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra &#xa0;V, Flanders &#xa0;SA, O&#x2019;Malley &#xa0;M, et al. &#xa0;Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med &#xa0;2020;174:576&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>(ONS) OfNS . Technical article: updated estimates of the prevalence of post-acute symptoms among people with coronavirus (COVID-19) in the UK: 26 April 2020 to 1 august 2021. ONS website, technical article &#xa0;2022;1:1&#x2013;2.</Citation></Reference><Reference><Citation>Stephenson &#xa0;T, Pinto Pereira &#xa0;SM, Shafran &#xa0;R, et al. &#xa0;Physical and mental health 3 months after SARS-CoV-2 infection (Long COVID) among adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc Health &#xa0;2022;6:230&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi &#xa0;P, Gorelik &#xa0;Y, Zayyad &#xa0;H, et al. &#xa0;Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel. npj Vaccines 2022;7:101. 10.1038/s41541-022-00526-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-022-00526-5</ArticleId><ArticleId IdType="pmc">PMC9411827</ArticleId><ArticleId IdType="pubmed">36028498</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet &#xa0;M, Dercon &#xa0;Q, Luciano &#xa0;S, et al. &#xa0;Incidence, co-occurrence, and evolution of Long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med &#xa0;2021;18:e1003773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen &#xa0;N, Gurdasani &#xa0;D, O&#x2019;Hara &#xa0;ME, et al. &#xa0;Characteristics and impact of Long COVID: findings from an online survey. PloS One &#xa0;2022;17:e0264331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne &#xa0;P, Tahmasebi &#xa0;N, Gant &#xa0;V, et al. &#xa0;Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J Invest Med &#xa0;2022;70:61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Casals &#xa0;M, Brito-Zer&#xf3;n &#xa0;P, Mariette &#xa0;X. Systemic and organ-specific immune-related manifestations of COVID-19. Nat Rev Rheumatol &#xa0;2021;17:315&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8072739</ArticleId><ArticleId IdType="pubmed">33903743</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani &#xa0;D, Khunti &#xa0;K, Nafilyan &#xa0;V, et al. &#xa0;Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study. BMJ 2021;372:n693. 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Uuskula &#xa0;A, J&#xfc;rgenson &#xa0;T, Pisarev &#xa0;H, et al. &#xa0;Long-term mortality following COVID-19 infection: a National Cohort Study from Estonia. The Lancet Regional Health-Europe 2022;18:100394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9051903</ArticleId><ArticleId IdType="pubmed">35505834</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutmann &#xa0;C, Takov &#xa0;K, Burnap &#xa0;SA, et al. &#xa0;SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care. Nat Commun &#xa0;2021;12:1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8184784</ArticleId><ArticleId IdType="pubmed">34099652</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere &#xa0;JJ, Serafini &#xa0;RA, Pryce &#xa0;KD, et al. &#xa0;SARS-CoV-2 infection results in lasting and systemic perturbations post recovery. Science translational medicine 2022;14.664:eabq3059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Saud &#xa0;Z, Ponsford &#xa0;M, Bentley &#xa0;K, et al. &#xa0;Mechanically ventilated patients shed high titre live SARS-CoV2 for extended periods from both the upper and lower respiratory tract. Clin Infect Dis &#xa0;2022;75:e82&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9129116</ArticleId><ArticleId IdType="pubmed">35231086</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosey &#xa0;MM, Needham &#xa0;DM. Survivorship after COVID-19 ICU stay. Nat Rev Dis Primers &#xa0;2020;6:1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7362322</ArticleId><ArticleId IdType="pubmed">32669623</ArticleId></ArticleIdList></Reference><Reference><Citation>Kress &#xa0;JP, Hall &#xa0;JB. ICU-acquired weakness and recovery from critical illness. N Engl J Med &#xa0;2014;370:1626&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">24758618</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue &#xa0;S, Hatakeyama &#xa0;J, Kondo &#xa0;Y, et al. &#xa0;Post-intensive care syndrome: its pathophysiology, prevention, and future directions. Acute Med Surg &#xa0;2019;6:233&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6603316</ArticleId><ArticleId IdType="pubmed">31304024</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandharipande &#xa0;PP, Girard &#xa0;TD, Jackson &#xa0;JC, et al. &#xa0;Long-term cognitive impairment after critical illness. N Engl J Med &#xa0;2013;369:1306&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3922401</ArticleId><ArticleId IdType="pubmed">24088092</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham &#xa0;DM, Dinglas &#xa0;VD, Morris &#xa0;PE, et al. &#xa0;Physical and cognitive performance of patients with acute lung injury 1 year after initial trophic versus full enteral feeding. EDEN trial follow-up. Am J Respir Crit Care Med &#xa0;2013;188:567&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3827703</ArticleId><ArticleId IdType="pubmed">23805899</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg &#xa0;B, Mohn &#xa0;KG-I, Brokstad &#xa0;KA, et al. &#xa0;Long COVID in a prospective cohort of home-isolated patients. Nat Med &#xa0;2021;27:1607&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna &#xa0;BA, Lim &#xa0;EY, Mactavous &#xa0;L, et al. &#xa0;Evidence of previous SARS-CoV-2 infection in seronegative patients with Long COVID. EBioMedicine &#xa0;2022;81:104129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9235296</ArticleId><ArticleId IdType="pubmed">35772216</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera &#xa0;E, P&#xe9;rez-S&#xe1;nchez &#xa0;MC, San Miguel-Abella &#xa0;R, et al. &#xa0;Cognitive impairment in young adults with post COVID-19 syndrome. Sci Rep &#xa0;2023;13:6378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10113715</ArticleId><ArticleId IdType="pubmed">37076533</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn &#xa0;E, Duarte-Salles &#xa0;T, Fernandez-Bertolin &#xa0;S, et al. &#xa0;Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study. Lancet Infect Dis &#xa0;2022;22:1142&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9106320</ArticleId><ArticleId IdType="pubmed">35576963</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsvetanov &#xa0;KA, Spindler &#xa0;LRB, Stamatakis &#xa0;EA, et al. &#xa0;Hospitalisation for COVID-19 predicts long lasting cerebrovascular impairment: a prospective observational cohort study. NeuroImage: Clinical 2022;36:103253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9639388</ArticleId><ArticleId IdType="pubmed">36451358</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrani &#xa0;RD, Dabas &#xa0;N, Goldberger &#xa0;JJ. COVID-19 cardiac injury: implications for long-term surveillance and outcomes in survivors. Heart Rhythm &#xa0;2020;17:1984&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7319645</ArticleId><ArticleId IdType="pubmed">32599178</ArticleId></ArticleIdList></Reference><Reference><Citation>Moores &#xa0;LK, Tritschler &#xa0;T, Brosnahan &#xa0;S, et al. &#xa0;Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report. Chest &#xa0;2020;158:1143&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7265858</ArticleId><ArticleId IdType="pubmed">32502594</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai &#xa0;C, Chotirmall &#xa0;SH, Rello &#xa0;J, et al. &#xa0;Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated international task force (29 July 2020). Eur Respir Rev &#xa0;2020;29:200287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537943</ArticleId><ArticleId IdType="pubmed">33020069</ArticleId></ArticleIdList></Reference><Reference><Citation>Son &#xa0;K, Jamil &#xa0;R, Chowdhury &#xa0;A, et al. &#xa0;Circulating anti-nuclear autoantibodies in COVID-19 survivors predict Long COVID symptoms. Eur Respir J &#xa0;2023;61:2200970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie &#xa0;CE, Lowe &#xa0;DJ, McAuley &#xa0;A, et al. &#xa0;Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat Commun &#xa0;2022;13:5663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli &#xa0;M, Penfold &#xa0;RS, Merino &#xa0;J, et al. &#xa0;Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis &#xa0;2022;22:43&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani &#xa0;D, Bosworth &#xa0;ML, King &#xa0;S, et al. &#xa0;Risk of Long COVID in people infected with SARS-CoV-2 after two doses of a COVID-19 vaccine: community-based, matched cohort study. Open Forum Infectious Diseases 2022;9:ofac464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna &#xa0;BA, Metaxaki &#xa0;M, Wills &#xa0;MR, et al. &#xa0;Reduced incidence of long coronavirus disease referrals to the Cambridge University Teaching Hospital Long Coronavirus Disease Clinic. Clin Infect Dis &#xa0;2023;76:738&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9384550</ArticleId><ArticleId IdType="pubmed">35913432</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly &#xa0;Z, Bowe &#xa0;B, Xie &#xa0;Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med &#xa0;2022;28:1461&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>
United Kingdom COVID-19 cases . Our world in data, Edouard Mathieu, Hannah Ritchie, Lucas Rod&#xe9;s-Guirao, Cameron Appel, Charlie Giattino, Joe Hasell, Bobbie Macdonald, Saloni Dattani, Diana Beltekian, Esteban Ortiz-Ospina and Max Roser (2020) - &#x201c;Coronavirus Pandemic (COVID-19)&#x201d;. Published online at OurWorldInData.org. Retrieved from: https://ourworldindata.org/coronavirus/country/united-kingdom.</Citation></Reference><Reference><Citation>
Office of National Statistics . Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 2 February 2023. ONS website, statistical bulletin &#xa0;2023. https://tinyurl.com/5dm65vku.</Citation></Reference><Reference><Citation>Su &#xa0;Y, Yuan &#xa0;D, Chen &#xa0;DG, et al. &#xa0;Multiple early factors anticipate post-acute COVID-19 sequelae. Cell &#xa0;2022;185:881&#x2013;895.e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaassen &#xa0;F, Chitwood &#xa0;MH, Cohen &#xa0;T, et al. &#xa0;Changes in population immunity against infection and severe disease from SARS-CoV-2 omicron variants in the United States between December 2021 and November 2022. Clinical Infectious Diseases 2023:ciad210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10425195</ArticleId><ArticleId IdType="pubmed">37074868</ArticleId></ArticleIdList></Reference><Reference><Citation>Willyard &#xa0;C. Are repeat COVID infections dangerous? What the science says. Nature &#xa0;2023;616:650&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">37100944</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki &#xa0;A, Putrino &#xa0;D. Why we need a deeper understanding of the pathophysiology of Long COVID. Lancet Infect Dis &#xa0;2023;23:393&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9928485</ArticleId><ArticleId IdType="pubmed">36967698</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein &#xa0;SR, Ramelli &#xa0;SC, Grazioli &#xa0;A, et al. &#xa0;SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 2022;612:758&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlefield &#xa0;KM, Watson &#xa0;RO, Schneider &#xa0;JM, et al. &#xa0;SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog &#xa0;2022;18:e1010359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9176759</ArticleId><ArticleId IdType="pubmed">35617421</ArticleId></ArticleIdList></Reference><Reference><Citation>Opsteen &#xa0;S, Files &#xa0;JK, Fram &#xa0;T, et al. &#xa0;The role of immune activation and antigen persistence in acute and Long COVID. J Investig Med 2023;71:545&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9996119</ArticleId><ArticleId IdType="pubmed">36879504</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna &#xa0;BA, Lim &#xa0;EY, Mactavous &#xa0;L, et al. &#xa0;Spontaneous, persistent T-cell dependent IFN-&#x3b3; release in patients who progress to Long COVID. Research Square 2022. 10.21203/rs.3.rs-2034285/v2.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-2034285/v2</ArticleId><ArticleId IdType="pmc">PMC10881041</ArticleId><ArticleId IdType="pubmed">38381822</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank &#xa0;Z, Senussi &#xa0;Y, Alter &#xa0;G, et al. &#xa0;Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. Clin Infect Dis 2023;76:e487&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan &#xa0;A, Zlitni &#xa0;S, Brooks &#xa0;EF, et al. &#xa0;Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med 2022;3:371&#x2013;387.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler &#xa0;C, Wang &#xa0;Z, Lorenzi &#xa0;JCC, et al. &#xa0;Evolution of antibody immunity to SARS-CoV-2. Nature &#xa0;2021;591:639&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasa &#xa0;S, Desai &#xa0;M, Thoguluva Chandrasekar &#xa0;V, et al. &#xa0;Prevalence of gastrointestinal symptoms and fecal viral shedding in patients with coronavirus disease 2019: a systematic review and meta-analysis. JAMA Netw Open &#xa0;2020;3:e2011335&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7290409</ArticleId><ArticleId IdType="pubmed">32525549</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh &#xa0;D, Lim &#xa0;JCT, Fern&#xe1;ndez &#xa0;SB, et al. &#xa0;Persistence of residual SARS-CoV-2 viral antigen and RNA in tissues of patients with Long COVID-19. Front Immunol 2022;13:939989.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9483160</ArticleId><ArticleId IdType="pubmed">36131932</ArticleId></ArticleIdList></Reference><Reference><Citation>Sneller &#xa0;MC, Liang &#xa0;CJ, Marques &#xa0;AR, et al. &#xa0;A longitudinal study of COVID-19 sequelae and immunity: baseline findings. Ann Intern Med &#xa0;2022;175:969&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9128805</ArticleId><ArticleId IdType="pubmed">35605238</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso &#xa0;MJ, Anglin &#xa0;K, Durstenfeld &#xa0;MS, et al. &#xa0;Effect of oral nirmatrelvir on Long COVID symptoms: a case series. Pathog Immun 2022;7:95&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9254867</ArticleId><ArticleId IdType="pubmed">35800257</ArticleId></ArticleIdList></Reference><Reference><Citation>Smatti &#xa0;MK, Cyprian &#xa0;FS, Nasrallah &#xa0;GK, et al. &#xa0;Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses &#xa0;2019;11:762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6723519</ArticleId><ArticleId IdType="pubmed">31430946</ArticleId></ArticleIdList></Reference><Reference><Citation>

Woodruff &#xa0;MC, Ramonell &#xa0;RP, Saini &#xa0;AS, et al.  &#xa0;Relaxed peripheral tolerance drives broad de novo autoreactivity in severe COVID-19. medRxiv &#xa0;2021. https://doi.org/2020.10.21.20216192.</Citation></Reference><Reference><Citation>Bastard &#xa0;P, Rosen &#xa0;LB, Zhang &#xa0;Q, et al. &#xa0;Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science &#xa0;2020;370:eabd4585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang &#xa0;SE, Feng &#xa0;A, Meng &#xa0;W, et al. &#xa0;New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat Commun &#xa0;2021;12:5417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440763</ArticleId><ArticleId IdType="pubmed">34521836</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang &#xa0;EY, Mao &#xa0;T, Klein &#xa0;J, et al. &#xa0;Diverse functional autoantibodies in patients with COVID-19. Nature 2021;595:283&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin &#xa0;LB, Weinstock &#xa0;LB, Molderings &#xa0;GJ. COVID-19 hyperinflammation and post-COVID-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis &#xa0;2020;100:327&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee &#xa0;D, Le Pen &#xa0;J, Yatim &#xa0;A, et al. &#xa0;Inborn errors of OAS&#x2013;RNase L in SARS-CoV-2&#x2013;related multisystem inflammatory syndrome in children. Science &#xa0;2022;379:eabo3627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10451000</ArticleId><ArticleId IdType="pubmed">36538032</ArticleId></ArticleIdList></Reference><Reference><Citation>Florencio &#xa0;LL, Fern&#xe1;ndez-de-Las-Pe&#xf1;as &#xa0;C. Long COVID: systemic inflammation and obesity as therapeutic targets. Lancet Respir Med &#xa0;2022;10:726&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9034853</ArticleId><ArticleId IdType="pubmed">35472305</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaylis &#xa0;NB, Ritter &#xa0;A, Kelly &#xa0;SA, et al. &#xa0;Reduced cell surface levels of C-C chemokine receptor 5 and immunosuppression in long coronavirus disease 2019 syndrome. Clin Infect Dis &#xa0;2022;75:1232&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9383814</ArticleId><ArticleId IdType="pubmed">35452519</ArticleId></ArticleIdList></Reference><Reference><Citation>

Klein &#xa0;J, Wood &#xa0;J, Jaycox &#xa0;J, et al.  &#xa0;Distinguishing features of Long COVID identified through immune profiling. medRxiv 2022. https://doi.org/2022.08.09.22278592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso &#xa0;MJ, Deveau &#xa0;T-M, Munter &#xa0;SE, et al. &#xa0;Chronic viral coinfections differentially affect the likelihood of developing Long COVID. J Clin Invest 2023;133:e163669.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubchenko &#xa0;S, Kril &#xa0;I, Nadizhko &#xa0;O, et al. &#xa0;Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study. Rheumatol Int &#xa0;2022;42:1523&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9159383</ArticleId><ArticleId IdType="pubmed">35650445</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso &#xa0;MJ, Deveau &#xa0;T-M, Munter &#xa0;SE, et al. &#xa0;Evidence of recent Epstein-Barr virus reactivation in individuals experiencing Long COVID. Int J Clin Pract 2023;2023:1068000.</Citation></Reference><Reference><Citation>Sausen &#xa0;DG, Bhutta &#xa0;MS, Gallo &#xa0;ES, et al. &#xa0;Stress-induced Epstein-Barr virus reactivation. Biomolecules &#xa0;2021;11:1380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8470332</ArticleId><ArticleId IdType="pubmed">34572593</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera &#xa0;MR, Greenwood &#xa0;EJ, Crozier &#xa0;TW, et al. &#xa0;Human cytomegalovirus infection of epithelial cells increases SARS-CoV-2 superinfection by upregulating the ACE2 receptor. J Infect Dis &#xa0;2023;227:543&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9927080</ArticleId><ArticleId IdType="pubmed">36408607</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius &#xa0;E, Venter &#xa0;C, Laubscher &#xa0;GJ, et al. &#xa0;Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/post-acute sequelae of COVID-19 (PASC). Cardiovasc Diabetol &#xa0;2022;21:148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius &#xa0;E, Vlok &#xa0;M, Venter &#xa0;C, et al. &#xa0;Persistent clotting protein pathology in Long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol &#xa0;2021;20:1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar &#xa0;LM, Venter &#xa0;C, Vlok &#xa0;M, et al. &#xa0;SARS-CoV-2 spike protein S1 induces fibrin (ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. Biosci Rep 2021;41:BSR20210611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8380922</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger &#xa0;A, Vlok &#xa0;M, Turner &#xa0;S, et al. &#xa0;Proteomics of fibrin amyloid microclots in Long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc Diabetol &#xa0;2022;21:1&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9491257</ArticleId><ArticleId IdType="pubmed">36131342</ArticleId></ArticleIdList></Reference><Reference><Citation>Maher &#xa0;AK, Burnham &#xa0;KL, Jones &#xa0;EM, et al. &#xa0;Transcriptional reprogramming from innate immune functions to a pro-thrombotic signature by monocytes in COVID-19. Nat Commun &#xa0;2022;13:7947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9791976</ArticleId><ArticleId IdType="pubmed">36572683</ArticleId></ArticleIdList></Reference><Reference><Citation>Badrfam &#xa0;R, Zandifar &#xa0;A. From encephalitis lethargica to COVID-19: is there another epidemic ahead? &#xa0;Clin Neurol Neurosurg &#xa0;2020;196:106065&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7347327</ArticleId><ArticleId IdType="pubmed">32659638</ArticleId></ArticleIdList></Reference><Reference><Citation>Foley &#xa0;PB. Encephalitis lethargica and the influenza virus. II. The influenza pandemic of 1918/19 and encephalitis lethargica: epidemiology and symptoms. J Neural Transm &#xa0;2009;116:1295&#x2013;308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2758910</ArticleId><ArticleId IdType="pubmed">19707848</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam &#xa0;MF, Cotler &#xa0;J, Jason &#xa0;LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue Biomed Health Behav &#xa0;2020;8:61&#x2013;9.</Citation></Reference><Reference><Citation>Lee &#xa0;SH, Shin &#xa0;H-S, Park &#xa0;HY, et al. &#xa0;Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in Middle East respiratory syndrome survivors. Psychiatry Investig &#xa0;2019;16:59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6354037</ArticleId><ArticleId IdType="pubmed">30605995</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky &#xa0;H, Patcai &#xa0;J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol &#xa0;2011;11:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee &#xa0;AM, Wong &#xa0;JG, McAlonan &#xa0;GM, et al. &#xa0;Stress and psychological distress among SARS survivors 1 year after the outbreak. Can J Psychiatry &#xa0;2007;52:233&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">17500304</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong &#xa0;KC, Ng &#xa0;A-K, Lee &#xa0;L-U, et al. &#xa0;Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome. Eur Respir J &#xa0;2004;24:436&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">15358703</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam &#xa0;MH-B, Wing &#xa0;Y-K, Yu &#xa0;MW-M, et al. &#xa0;Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med &#xa0;2009;169:2142&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui &#xa0;D, Joynt &#xa0;G, Wong &#xa0;K, et al. &#xa0;Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax &#xa0;2005;60:401&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1758905</ArticleId><ArticleId IdType="pubmed">15860716</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed &#xa0;H, Patel &#xa0;K, Greenwood &#xa0;DC, et al. &#xa0;Long-term clinical outcomes in survivors of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis. J Rehabil Med &#xa0;2020;52:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler-Davis &#xa0;S, Platts &#xa0;K, Thelwell &#xa0;M, et al. &#xa0;A mixed-methods systematic review of post-viral fatigue interventions: are there lessons for Long COVID? &#xa0;PloS One &#xa0;2021;16:e0259533.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8577752</ArticleId><ArticleId IdType="pubmed">34752489</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason &#xa0;LA, Dorri &#xa0;JA. ME/CFS and post-exertional malaise among patients with Long COVID. Neurol Int &#xa0;2022;15:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9844405</ArticleId><ArticleId IdType="pubmed">36648965</ArticleId></ArticleIdList></Reference><Reference><Citation>Piraino &#xa0;B, Vollmer-Conna &#xa0;U, Lloyd &#xa0;A. Genetic associations of fatigue and other symptom domains of the acute sickness response to infection. Brain Behav Immun &#xa0;2012;26:552&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7127134</ArticleId><ArticleId IdType="pubmed">22227623</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollmer-Conna &#xa0;U, Piraino &#xa0;BF, Cameron &#xa0;B, et al. &#xa0;Cytokine polymorphisms have a synergistic effect on severity of the acute sickness response to infection. Clin Infect Dis &#xa0;2008;47:1418&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">18937577</ArticleId></ArticleIdList></Reference><Reference><Citation>Broderick &#xa0;G, Katz &#xa0;BZ, Fernandes &#xa0;H, et al. &#xa0;Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue. J Transl Med &#xa0;2012;10:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3480896</ArticleId><ArticleId IdType="pubmed">22973830</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans &#xa0;RA, Leavy &#xa0;OC, Richardson &#xa0;M, et al. &#xa0;Clinical characteristics with inflammation profiling of Long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med &#xa0;2022;10:761&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie &#xa0;Y, Choi &#xa0;T, Al-Aly &#xa0;Z. Association of treatment with nirmatrelvir and the risk of post&#x2013;COVID-19 condition. JAMA Intern Med &#xa0;2023;183:554&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10037200</ArticleId><ArticleId IdType="pubmed">36951829</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairbank &#xa0;R. Long COVID exercise trials proposed by NIH raise alarm. Nature &#xa0;2023;616:228&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">37002390</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright &#xa0;J, Astill &#xa0;SL, Sivan &#xa0;M. The relationship between physical activity and Long COVID: a cross-sectional study. Int J Environ Res Public Health &#xa0;2022;19:5093.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9105041</ArticleId><ArticleId IdType="pubmed">35564488</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock &#xa0;C, Walther &#xa0;R, Tselmin &#xa0;S, Jarzebska &#xa0;N, Voit-Bak &#xa0;K, Toepfner &#xa0;N, Siepmann &#xa0;T, Passauer &#xa0;J, Hugo &#xa0;C, Wintermann &#xa0;G. Post COVID and apheresis&#x2013;where are we standing. Horm Metab Res 2022;54:715&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">36113501</ArticleId></ArticleIdList></Reference><Reference><Citation>Achleitner &#xa0;M, Steenblock &#xa0;C, D&#xe4;nhardt &#xa0;J, et al. &#xa0;Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis. Mol Psychiatry 2023. 10.1038/s41380-023-02084-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-02084-1</ArticleId><ArticleId IdType="pmc">PMC10152027</ArticleId><ArticleId IdType="pubmed">37131073</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger &#xa0;B, Harrer &#xa0;T, Mardin &#xa0;C, et al. &#xa0;Case report: neutralization of autoantibodies targeting G-protein-coupled receptors improves capillary impairment and fatigue symptoms after COVID-19 infection. Front Med &#xa0;8:754667. 10.3389/fmed.2021.754667.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.754667</ArticleId><ArticleId IdType="pmc">PMC8637609</ArticleId><ArticleId IdType="pubmed">34869451</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng &#xa0;LN, Bonilla &#xa0;HF, Shafer &#xa0;RW, et al. &#xa0;Case report of breakthrough Long COVID and the use of nirmatrelvir-ritonavir. Research Square, 15 Mar 2022 PPR: PPR469834.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>